Spain Respiratory Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-07-01 I 70 Pages I Mordor Intelligence
Spain Respiratory Devices Market Analysis
The Spain Respiratory Devices Market size is estimated at USD 639.77 million in 2025, and is expected to reach USD 879.84 million by 2030, at a CAGR of 6.58% during the forecast period (2025-2030). Robust public health coverage, the rapid expansion of home-based care, and continuous innovation in therapeutic equipment underpin this trajectory. Accelerated population ageing intensifies demand for ventilators and oxygen systems, while a growing burden of chronic obstructive pulmonary disease (COPD) and sleep apnea broadens the addressable patient pool. Government incentives that promote local manufacturing and digital health adoption further support revenue growth. At the same time, heightened regulatory costs, workforce shortages, and stricter environmental rules temper short-term momentum yet encourage scale advantages for established suppliers.
Spain Respiratory Devices Market Trends and Insights
Growing Prevalence of COPD, Asthma, Tuberculosis, and Sleep Apnea
COPD affects 11.8% of Spanish adults and drove a 35.9% rise in hospital discharges for respiratory diseases, a pattern that strengthens long-term sales of ventilators, nebulizers, and spirometers. Sleep apnea remains widely underdiagnosed despite affecting nearly half of older adults at elevated dementia risk, creating fresh headroom for positive airway pressure devices and home sleep testing kits. Advances in tuberculosis PCR kits with 100% sensitivity expand demand for portable diagnostic systems in public health laboratories. Together, these epidemiological shifts lengthen device replacement cycles and enlarge the Spain respiratory devices market far beyond acute care settings.
Rapid Ageing of Spain's Population
The cohort aged 90 years or older swelled 58.29% from 2013 to 2023, reaching 608,321 citizens. An ageing index of 142.35% highlights growing demand for non-invasive ventilation, oxygen concentrators, and airway clearance devices tailored to home use. With single-person households forecast to account for 33.5% of all households by 2039, manufacturers prioritise intuitive interfaces and remote monitoring features that let older adults remain independent. Hospitals already maintain dedicated non-invasive ventilation units in 83% of facilities, signalling sustained procurement for ageing-related disorders. These demographic realities embed structural growth in the Spain respiratory devices market.
High Upfront Cost of Advanced Devices
Hospitals operate under strict budget ceilings even after recent public-health outlays, causing extended procurement cycles for premium ventilators and AI-enabled monitors. Regional authorities lean on cost-per-quality-adjusted-life-year thresholds that favour proven mid-range products. The Canary Islands' decision to reduce its IGIC tax on medical devices to zero illustrates how targeted fiscal levers can mitigate affordability constraints. In the absence of nationwide VAT relief, price sensitivity will continue to cap immediate growth in the Spain respiratory devices market.
Other drivers and restraints analyzed in the detailed report include:
Expansion of Home-based Respiratory Care and Tele-monitoring / Surge in e-cigarette-related Lung Injuries / EU MDR Compliance Delaying Product Launches /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Therapeutic devices accounted for 56.54% of 2024 revenue, reflecting a clinical preference for continuous airway pressure systems, ventilators, and oxygen concentrators. Positive airway pressure innovations such as KPAP enhance comfort and adherence among sleep apnea patients, locking in recurring mask and tubing sales. Ventilator development programs funded under national recovery schemes lower price barriers, further widening penetration. Nebulizers remain critical for COPD management, while portable oxygen systems support growing homecare demand. The Spain respiratory devices market size for therapeutic equipment is projected to rise in tandem with ageing-linked comorbidities.
Diagnostic and monitoring devices hold a smaller base but record the fastest 7.65% CAGR. Connected spirometers, wearable capnographs, and home sleep tests gain popularity amid wider telehealth rollouts. Early diagnosis of respiratory disease lowers hospital admissions, strengthening policy support for screening tools. As a result, diagnostic platforms capture a rising share of the Spain respiratory devices market.
The Spain Respiratory Devices Market Report is Segmented by Product Type (Diagnostic & Monitoring Devices, Therapeutic Devices, Disposables), Indication (COPD, Asthma, Sleep Apnea, Cystic Fibrosis, Tuberculosis, Other Respiratory Disorders), End User (Hospitals and Clinics, Homecare Settings, Ambulatory Surgical Centers, Long-Term Care Facilities), and Geography (Spain). The Market Forecasts are Provided in Terms of Value (USD).
List of Companies Covered in this Report:
Koninklijke Philips / Resmed / Dragerwerk AG / Fisher & Paykel Healthcare / Medtronic / Hamilton Medical / GEHealthcare / Smiths Medical MD, Inc. / Fosun Pharma (Breas Medical AB) / Invacare / GlaxoSmithKline / Rotech Healthcare / Becton Dickinson & Co. / Air Liquide / Teleflex / Drive DeVilbiss Healthcare / Apex Medical / Lowenstein Medical GmbH / Vyaire Medical / Vapotherm Inc. /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Prevalence of COPD, Asthma, TB & Sleep-Apnea
4.2.2 Rapid Ageing of Spain's Population
4.2.3 Expansion of Home-Based Respiratory Care & Tele-Monitoring
4.2.4 Surge In E-Cigarette-Related Lung Injuries
4.2.5 Post-COVID Government Incentives for Local Ventilator Output
4.2.6 Adoption of AI-Enabled Predictive Maintenance for Ventilators
4.3 Market Restraints
4.3.1 High Upfront Cost of Advanced Devices
4.3.2 EU MDR Compliance Delaying Product Launches
4.3.3 Shortage of Respiratory Therapists
4.3.4 Environmental Curbs on Single-Use Plastics In Disposables
4.4 Supply-Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces Analysis
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Buyers
4.7.3 Bargaining Power of Suppliers
4.7.4 Threat of Substitutes
4.7.5 Intensity of Competitive Rivalry
5 Market Size & Growth Forecasts (Value)
5.1 By Product Type
5.1.1 Diagnostic & Monitoring Devices
5.1.1.1 Spirometers
5.1.1.2 Sleep Test Devices
5.1.1.3 Peak Flow Meters
5.1.1.4 Other Diagnostic & Monitoring Devices
5.1.2 Therapeutic Devices
5.1.2.1 Positive Airway Pressure (PAP) Devices
5.1.2.2 Humidifiers
5.1.2.3 Nebulizers
5.1.2.4 Ventilators
5.1.2.5 Inhalers
5.1.2.6 Oxygen Concentrators
5.1.2.7 Other Therapeutic Devices
5.1.3 Disposables
5.1.3.1 Breathing Circuits
5.1.3.2 Masks
5.1.3.3 Filters
5.1.3.4 Other Disposables
5.2 By Indication
5.2.1 COPD
5.2.2 Asthma
5.2.3 Sleep Apnea
5.2.4 Cystic Fibrosis
5.2.5 Tuberculosis
5.2.6 Other Respiratory Disorders
5.3 By End User
5.3.1 Hospitals and Clinics
5.3.2 Homecare Settings
5.3.3 Ambulatory Surgical Centers
5.3.4 Long-term Care Facilities
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
6.3.1 Koninklijke Philips N.V.
6.3.2 ResMed
6.3.3 Dragerwerk AG
6.3.4 Fisher & Paykel Healthcare Ltd
6.3.5 Medtronic plc
6.3.6 Hamilton Medical AG
6.3.7 GE HealthCare
6.3.8 Smiths Medical MD, Inc.
6.3.9 Fosun Pharma (Breas Medical AB)
6.3.10 Invacare Corporation
6.3.11 GlaxoSmithKline plc
6.3.12 Rotech Healthcare Inc.
6.3.13 Becton Dickinson & Co.
6.3.14 Air Liquide Healthcare
6.3.15 Teleflex Inc.
6.3.16 DeVilbiss Healthcare LLC
6.3.17 Apex Medical Corp.
6.3.18 Lowenstein Medical GmbH
6.3.19 Vyaire Medical Inc.
6.3.20 Vapotherm Inc.
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-need Assessment
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.